Reduction of mitral valve regurgitation with Mitraclip® percutaneous system

Minerva Cardioangiologica

Volumn 58, Issue 5, 2010, Pages 589-598

  Tamburino, C ^a,b   Imme S ^a   Barbanti, M ^a   Mule M ^a   Pistritto, A M ^a   Aruta, P ^a   Cammalleri, V ^a   Scarabelli, M ^a   Mangiafico, S ^a   Scandura, S ^a   Ussia, G P ^a,b  

^a UNIVERSITY OF CATANIA   (Italy)

^b Excellence Through Newest Advances ETNA Foundation   (Italy)

Author keywords

Heart diseases; Mitral valve insufficiency; Percutaneous surgery

Indexed keywords

ADULT; AGED; CLIP; ENDOVASCULAR SURGERY; HUMAN; MAJOR CLINICAL STUDY; MITRAL VALVE REGURGITATION; MITRAL VALVE REPAIR; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW;

CARDIAC SURGICAL PROCEDURES; HEART VALVE PROSTHESIS IMPLANTATION; HUMANS; MITRAL VALVE INSUFFICIENCY; SURGICAL INSTRUMENTS;

EID: 79251586883     PISSN: 00264725     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (24)

1. Mirabel M, Iung B, Baron G, Messika-Zeitoun D, Dètaint D, Vanoverschelde JL et al. What are the characteristics of patients with severe, symptomatic, mitral regurgitation who are denied surgery? Eur Heart J 2007;28:1358-65.
2. Maisano F, Schreuder JJ, Oppizzi M, Fiorani B, Fino C, Alfieri O. The double-orifice technique as a standardized approach, to treat mitral regurgitation due to severe myxomatous disease: surgical technique. Eur J Cardiothorac Surg 2000;17:201-5.
3. Lorusso R, Borghetti V, Totaro P, Parrinello G, Coletti G, Minzioni G. The double-orifice technique for mitral valve reconstruction: predictors of outcome. Eur J Cardiothorac Surg 2001;20:583-9. (Pubitemid 32743343)
4. Alfieri O, Maisano F, De Bonis M, Stefano PL, Torracca L, Oppizzi M et al. The edge-to-edge technique in mitral valve repair: a simple solution for complex problems. J Thorac Cardiovasc Surg 2001;122:674-81.
5. Herrmann HC, Kar S, Siegel R, Fail P, Loghin C, Lim S et al. Effect of percutaneous mitral repair with the MitraClip device on mitral valve area and gradient. Eurointervention 2009;4:437-42.
6. Condado JA, Acquatella H, Rodriguez L, Whitlow P, Vélez-Gimo M, St Goar FG. Percutaneous edge-to-edge mitral valve repair: 2 year follow-up in the first human case. Catheter Cardiovasc Interv 2006;67:323-5.
7. Feldman T, Wasserman HS, Herrmann HC, Gray W, Block PC, Whitlow P et al. Percutaneous mitral valve repair using the edge-to-edge technique six-month results of the EVEREST phase 1 clinical trial. J Am Coll Card 2006;46:2134-40.
8. Feldman T, Kar S, Rinaldi M, Fail P, Hermiller J, Smalling R et al. Percutaneous mitral repair with the MitraClip system: safety and midterm durability in the initial EVEREST (Endovascular Valve Edge-to-Edge REpair Study) cohort. J Am Coll Cardiol 2009;54;686-94.
9. Franzen O, Baldus S, Rudolph V, Meyer S, Knap M, Koschyk D et al. Acute outcomes of MitraClip therapy for mitral regurgitation in high-surgical-risk patients: emphasis on adverse valve morphology and severe left ventricular dysfunction. Eur Heart J 2010 [Epub ahead of print].
10. Tamburino C, Ussia GP, Maisano F, Capodanno D, La Canna G, Scandura S et al. Percutaneous mitral valve repair with the Mitraclip system: acute results from a real world setting. Eur Heart J 2010 [Epub ahead of print].
11. Rosen SE, Borer JS, Hochreiter C, Supino P, Roman MJ, Devereux RB et al. Natural history of the asymptomatic/minimally symptomatic patient with severe mitral regurgitation secondary to mitral valve prolapse and normal right and left ventricular performance. Am J Cardiol 2010;74:374-80.
12. Ling LH, Enriquez-Sarano M, Seward JB, Tajik AJ, Schaff HV, Bailey KR et al. Clinical outcome of mitral regurgitation due to flail leaflet. N Engl J Med 2010;335:1417-23.
13. Bonow RO, Carabello BA, Kanu C, de Leon AC Jr, Faxon DP, Freed MD et al. ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (writing Committee to Revise the 1998 guidelines for the management of patients with valvular heart disease) developed in collaboration with the Society of Cardiovascular Anesthesiologists endorsed by the Society for Cardiovascular Angiography and Interventions and the Society of Thoracic Surgeons. J Am Coll Cardiol 2006;48:e1-148.
14. Wu AH, Aaronson KD, Bolling SF, Pagani FD, Welch K, Koelling TM. Impact of mitral valve annuloplasty on mortality risk in patients with mitral regurgitation and anular systolic dysfunction. J Am Coll Cardiol 2010;45:37-38
15. De Bonis M, Lorusso R, Lapenna E, Kassem S, De Cicco G, Torracca L et al. Similar long-term results of mitral valve repair for anterior compared with posterior leaflet prolapse. J Thorac Cardiovasc Surg 2006;131:364-70. (Pubitemid 43121559)
16. Gillinov AM, Cosgrove DM, Blackstone EH, Diaz R, Arnold JH, Lytle BW et et al. Durability of mitral valve repair for degenerative disease. J Thorac Cardiovasc Surg 1998;116:734-43.
17. Ussia GP, Barbanti M, Tamburino C. Feasibility of percutaneous transcatheter mitral valve repair with the MitraClip® system using conscious sedation. Catheter Cardiovasc Interv 2009 [Epub ahead of print].
18. Bagai J, Zhao D. Subcutaneous "figure-of-eight" stitch to achieve hemostasis after removal of large-caliber femoral venous sheaths. Cardiac Inteventions Today 2008; July/August: 22-23. [cited 2010 September 27]. Available at: http://bmctoday.net/citoday/2008/08/article.asp?f=CIT0808-02.php.
19. Dang NC, Aboodi MS, Sakaguchi T, Wasserman HS, Argenziano M, Cosgrove DM et al. Surgical revision after percutaneous mitral valve repair with a clip: initial multicenter experience. Ann Thorac Surg 2005;80:2338-42.
20. Feldman T Endovascular Valve Edge-to-Edge REpair Study (EVEREST II) Randomized Clinical Trial: primary safety and efficacy endpoints. Presented at the American College of Cardiology Congress, March 14, 2010, Atlanta, GE, USA.
21. Whitlow PL. Presented at the Transcatheter Cardiovascular Therapeutics (TCD Congress, 21-25 September 2009, San Francisco, CA, USA.
22. Scott Lim. Presented at the Transcatheter Cardiovascular Therapeutics (TCT) Congress, 21-25 September 2009, San Francisco, CA, USA.
23. Glower DD, Tuttle RH, Shaw LK, Orozco RE, Rankin JS. Patient survival characteristics after routine mitral valve repair for ischemic mitral regurgitation. J Thorac Cardiovasc Surg 2005;129:860-8.
24. David TE. Outcomes of mitral valve repair for mitral regurgitation due to degenerative disease. Semin Thorac Cardiovasc Surg 2007;19:116-20.